Chuncheon--(뉴스와이어)--BARRICURE, the dermatology-focused medical device brand of MEDIPEAU Inc, Ltd., participated as an official sponsor at the Sarawak Paediatric Dermatology Update 2025 (SPDU 2025), held on July 26, 2025, at the Imperial Hotel in Kuching, Malaysia.

This year’s SPDU 2025 was themed “Back to Basics: The ABCs of Paediatric Dermatology”, bringing together pediatric dermatology experts from Malaysia and across Southeast Asia to share the latest clinical insights and treatment experiences.

Working with its official Malaysian distribution partner, CHAYA AND LIGHT SDN. BHD., BARRICURE operated a brand booth and prominently showcased its flagship products, BARRICURE Rich Cream MD and BARRICURE Lotion MD.

Both products apply BARRICURE’s patented MDmellar® formulation technology, designed to help support balanced lipid delivery and skin barrier recovery for sensitive or compromised skin. They also contain DERMA-CLERA®, a patented, naturally derived ingredient that may help alleviate discomfort associated with conditions such as dermatitis, first-degree burns, dryness, and barrier impairment.

A BARRICURE spokesperson said that partnering with CHAYA AND LIGHT allowed it to directly introduce innovative and safe skin solutions to medical professionals across Malaysia. The spokesperson added that it will continue strengthening its presence in the global pharmaceutical and skin health markets.

MEDIPEAU Inc. plans to further expand the BARRICURE brand worldwide, leveraging its proprietary technologies and global partnerships to accelerate growth across Southeast Asia and beyond.

About MEDIPEAU

MEDIPEAU is a biotechnology company dedicated to the reconstruction of healthy skin through natural compound chemistry and cutting-edge biotechnologies. The company operates a “Pruritus Research Institute,” specializing in the study of skin diseases accompanied by itching, such as atopic dermatitis, psoriasis, burns, and scars. Committed to outstanding research and development, MEDIPEAU ensures consistent product quality by manufacturing and managing its products in facilities certified for Good Manufacturing Practice (GMP) for medical devices.